Finding a trusted, medically supervised weight loss program close to home can make all the difference
Focuses on holistic health approaches
Post-marketing surveillance systems track adverse events reported by patients and providers
Weight Loss Progression: Weight reduction follows a more gradual trajectory
In the 12 mg dose group, 16% of subjects discontinued due to adverse events (AEs), but the overall incidence of severe adverse events (SAEs) was low, about 6%-8%
Secondary outcome measurements included reduction in body weight from baseline by at least 5% or 10% by week 26, changes in waist circumference, total cholesterol, HDL, LDL, VLDL, and triglycerides, and levels of different glycemic variables including HbA1C, fasting plasma glucose, fasting insulin, insulin resistance, and the functioning of beta-cells